Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats

• Published in: International journal of molecular sciences Vol. 16; no. 7; pp. 14441 - 14463
• Main Authors: Parray, Hilal, Yun, Jong
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.06.2015; MDPI
• Subjects: Adipose Tissue, White - drug effects; Adipose Tissue, White - metabolism; Animals; Annexin A2 - genetics; Annexin A2 - metabolism; Body fat; Carbonic Anhydrases - genetics; Carbonic Anhydrases - metabolism; Diet, High-Fat - adverse effects; Galectin 1 - antagonists & inhibitors; Galectin 1 - metabolism; Isoenzymes - genetics; Isoenzymes - metabolism; L-Lactate Dehydrogenase - genetics; L-Lactate Dehydrogenase - metabolism; Obesity; Obesity - etiology; Obesity - genetics; Obesity - metabolism; Phosphatidylethanolamine Binding Protein - genetics; Phosphatidylethanolamine Binding Protein - metabolism; Proteome - drug effects; Proteome - genetics; Proteome - metabolism; Proteomics; Rats; Rats, Sprague-Dawley; Rodents; Thiogalactosides - pharmacology; Tissues; Voltage-Dependent Anion Channel 1 - genetics; Voltage-Dependent Anion Channel 1 - metabolism; thiodigalactoside; white adipose tissue; obesity; galectin; proteome
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms160714441

Previously, galectin-1 (GAL1) was found to be up-regulated in obesity-prone subjects, suggesting that use of a GAL1 inhibitor could be a novel therapeutic approach for treatment of obesity. We evaluated thiodigalactoside (TDG) as a potent inhibitor of GAL1 and identified target proteins of TDG by performing comparative proteome analysis of white adipose tissue (WAT) from control and TDG-treated rats fed a high fat diet (HFD) using two dimensional gel electrophoresis (2-DE) combined with MALDI-TOF-MS. Thirty-two spots from a total of 356 matched spots showed differential expression between control and TDG-treated rats, as identified by peptide mass fingerprinting. These proteins were categorized into groups such as carbohydrate metabolism, tricarboxylic acid (TCA) cycle, signal transduction, cytoskeletal, and mitochondrial proteins based on functional analysis using Protein Annotation Through Evolutionary Relationship (PANTHER) and Database for Annotation, Visualization, Integrated Discovery (DAVID) classification. One of the most striking findings of this study was significant changes in Carbonic anhydrase 3 (CA3), Voltage-dependent anion channel 1 (VDAC1), phosphatidylethanolamine-binding protein 1 (PEBP1), annexin A2 (ANXA2) and lactate dehydrogenase A chain (LDHA) protein levels between WAT from control and TDG-treated groups. In addition, we confirmed increased expression of thermogenic proteins as well as reduced expression of lipogenic proteins in response to TDG treatment. These results suggest that TDG may effectively prevent obesity, and TDG-responsive proteins can be used as novel target proteins for obesity treatment.